Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v1-EN
Language French English
Date Updated 2024-04-09 2023-10-20
Drug Identification Number 02422018 02422018
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION USP LIDOCAINE HYDROCHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 50mL 50mL
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-11-01 2023-11-01
Actual start date
Estimated end date 2024-03-31 2023-12-15
Actual end date 2024-04-08
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments